ISRCTN51624203已完成未知
The measurement of VItal SIgns by Lifelight® software in comparisON to the standard of care – Multi-site Development (the VISION-MD study)
Xim (United Kingdom)0 个研究点目标入组 9,500 人开始时间: 2022年8月18日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 9,500
研究概览
简要总结
2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36630158/ (added 02/10/2023)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •16 years old or above
排除标准
- •Does not meet the inclusion criteria
研究者
相似试验
已完成
不适用
The Measurement of VItal SIgns by Lifelight® Software in comparisON to the Standard of Care - Multi-site DevelopmentRespiratory DisorderCardiovascular DiseasesCritical CareTrauma and Emergency CarePrimary CareDiabetesNCT04763746Xim Limited1,869
已完成
不适用
The VISION-Acute StudyHypoxiaHypertensionHypotensionNCT04589923Xim Limited127
已完成
不适用
Lifelight Non-Invasive Blood Pressure and Heart Rate Validation StudyHypertensionNCT06535152Xim Limited85
已完成
不适用
Safer and more efficient vital signs monitoring: an observational studyPatients at risk of deterioration in the hospitalSigns and SymptomsISRCTN10863045niversity of Portsmouth200,640
进行中（未招募）
不适用
CRADLE 5: Evaluating the national scale-up of the CRADLE vital signs alert device in Sierra Leone. Helping pregnant women get to the right place at the right time.Reduction of maternal and perinatal morbidity and mortality from obstetric haemorrhage, sepsis and pre-eclampsia in pregnant or postpartum women in Sierra LeonePregnancy and ChildbirthISRCTN94429427King's College London50,000